Literature DB >> 24276982

Chromate metabolism in liver microsomes.

K W Jennette1.   

Abstract

The carcinogenicity and mutagenicity of various chromium compounds have been found to be markedly dependent on the oxidation state of the metal. The carcinogen chromate was reduced to chromium(III) by rat liver microsomes in vitro. Metabolism of chromate by microsomal enzymes occurred only in the presence of either NADPH or NADH as cofactor. The chromium(III) generated upon metabolism formed a complex with the NADP(+) cofactor. Significant binding of chromium to DNA occurred only when chromate was incubated in the presence of microsomes and NADPH. Specific inhibitors of the mixed function oxidase enzymes, 2'-AMP, metyrapone, and carbon monoxide, inhibited the rate of reduction of chromate by microsomes and NADPH. The possible relationship of metabolism of chromate and its interaction with nucleic acids to its carcinogenicity and mutagenicity is discussed.

Entities:  

Year:  1979        PMID: 24276982     DOI: 10.1007/BF02783843

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  36 in total

1.  THE BINDING OF CR51 TO HEMOGLOBIN. I. IN VITRO STUDIES.

Authors:  H A PEARSON
Journal:  Blood       Date:  1963-08       Impact factor: 22.113

2.  Reaction of chromium compounds with body tissues and their constituents.

Authors:  A M BAETJER; C M DAMRON; J H CLARK; V BUDACZ
Journal:  AMA Arch Ind Health       Date:  1955-09

3.  Experimental considerations biological ESR studies. II. Chromium-tissue complexes detected by electron spin resonance.

Authors:  P I Gutierrez; T Sarna; H M Swartz
Journal:  Phys Med Biol       Date:  1976-11       Impact factor: 3.609

4.  Substrate interaction with hydroxylase system in liver microsomes.

Authors:  Y Imai; R Sato
Journal:  Biochem Biophys Res Commun       Date:  1966-03-22       Impact factor: 3.575

5.  The uptake and retention of chromium by cells.

Authors:  C J Sanderson
Journal:  Transplantation       Date:  1976-06       Impact factor: 4.939

6.  Morphological effects of chromium and cobalt complexes on bacteria.

Authors:  A Theodotou; R J Stretton; A H Norbury; A G Massey
Journal:  Bioinorg Chem       Date:  1976

7.  Toxicity and mutagenicity of hexavalent chromium on Salmonella typhimurium.

Authors:  F L Petrilli; S De Flora
Journal:  Appl Environ Microbiol       Date:  1977-04       Impact factor: 4.792

8.  Properties of electrophoretically homogeneous phenobarbital-inducible and beta-naphthoflavone-inducible forms of liver microsomal cytochrome P-450.

Authors:  D A Haugen; M J Coon
Journal:  J Biol Chem       Date:  1976-12-25       Impact factor: 5.157

9.  Effects of potassium dichromate on nucleic acid and protein syntheses and on precursor uptake in BHK fibroblasts.

Authors:  A G Levis; M Buttignol; V Bianchi; G Sponza
Journal:  Cancer Res       Date:  1978-01       Impact factor: 12.701

10.  Direct interaction with cellular targets as the mechanism for chromium carcinogenesis.

Authors:  G Raffetto; S Parodi; C Parodi; M De Ferrari; R Troiano; G Brambilla
Journal:  Tumori       Date:  1977 Nov-Dec
View more
  10 in total

1.  Enhanced production of micronuclei by hexavalent chromium in cultured CHO cells.

Authors:  W R Howard; S A Hoffman; T S Kochhar
Journal:  Bull Environ Contam Toxicol       Date:  1992-10       Impact factor: 2.151

2.  Reduction of chromium(VI) in Chinese hamster V-79 cells.

Authors:  M Sugiyama; K Tsuzuki; T Hidaka; R Ogura; M Yamamoto
Journal:  Biol Trace Elem Res       Date:  1991-07       Impact factor: 3.738

3.  Effects of vitamin E and vitamin B2 on chromate-induced DNA lesions.

Authors:  M Sugiyama
Journal:  Biol Trace Elem Res       Date:  1989 Jul-Sep       Impact factor: 3.738

Review 4.  Mechanism of chromium(VI) carcinogenesis. Reactive intermediates and effect on gene expression.

Authors:  K E Wetterhahn; J W Hamilton; J Aiyar; K M Borges; R Floyd
Journal:  Biol Trace Elem Res       Date:  1989 Jul-Sep       Impact factor: 3.738

5.  Alterations in the prooxidant and antioxidant status of human leukemic T-lymphocyte MOLT4 cells treated with potassium chromate.

Authors:  S N Mattagajasingh; H P Misra
Journal:  Mol Cell Biochem       Date:  1995-01-12       Impact factor: 3.396

6.  Use of ascorbic acid in the 51Cr labelling of mouse fibrosarcoma cells.

Authors:  K A Chaubal; V S Aroskar; C S Godbole; C N Shenoy
Journal:  Radiat Environ Biophys       Date:  1984       Impact factor: 1.925

7.  The ambiguous effect of ascorbic acid on chromate induced proteinuria in rats.

Authors:  D Appenroth; K Winnefeld; H Schröter; M Rost
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

Review 8.  Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.

Authors:  Chad M Thompson; Deborah M Proctor; Mina Suh; Laurie C Haws; Christopher R Kirman; Mark A Harris
Journal:  Crit Rev Toxicol       Date:  2013-03       Impact factor: 5.635

9.  Effect of different oxidation states of chromium in causing chromosome alterations in cultured CHO cells.

Authors:  T S Kochhar; W R Howard
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

10.  In vitro assessment of the toxicity of metal compounds : II. Mutagenesis.

Authors:  J D Heck; M Costa
Journal:  Biol Trace Elem Res       Date:  1982-12       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.